EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Increased Use of Hyperosmolar Therapy for Suspected Clinically Apparent Brain Injury in Pediatric Patients with Diabetic Ketoacidosis during the Peak of the COVID-19 Pandemic

Svetlana Azova iD, Enju Liu iD, Joseph Wolfsdorf iD

Pediatric Diabetes · 2023

DOI: 10.1155/2023/5123197 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Diabetes, 2023. Verfasst von Svetlana Azova und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Boston Children's Hospital, Boston, Massachusetts 02115, USA. Hauptthemen laut MEDLINE: Diabetic Ketoacidosis, Hyperglycemic Hyperosmolar Nonketotic Coma, COVID-19, Diabetes Mellitus, Type 1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incidence of pediatric diabetic ketoacidosis (DKA) increased during the peak of the COVID-19 pandemic. The objective of this study was to investigate whether rates of hyperosmolar therapy administration for suspected clinically apparent brain injury (CABI) complicating DKA also increased during this period as compared to the three years immediately preceding the pandemic and to compare the characteristics of patients with suspected CABI before the pandemic, patients with suspected CABI during the peak of the pandemic, and those with DKA but without suspected CABI during the pandemic. Patients aged ≤18 years presenting with DKA before (March 11, 2017–March 10, 2020) and during the peak of the pandemic (March 11, 2020–March 10, 2021) were identified through a rigorous search of two databases. Predefined criteria were used to diagnose suspected CABI. Biochemical, clinical, and sociodemographic data were collected from a comprehensive review of the electronic medical record. The proportion of patients with DKA who received hyperosmolar therapy was significantly higher ( P = 0.014) during the pandemic compared to the prepandemic period; however, this was only significant among patients with newly diagnosed diabetes. Both groups with suspected CABI had more severe acidosis, lower Glasgow Coma Scale scores, and longer hospital admissions ( P < 0.001 for all) than cases without suspected CABI. During the pandemic, the blood urea nitrogen concentration was significantly higher in patients with suspected CABI than those without suspected CABI, suggesting they were more severely dehydrated. The clinical, biochemical, and sociodemographic characteristics of patients with suspected CABI were indistinguishable before and during the pandemic. In conclusion, administration of hyperosmolar therapy for suspected CABI was more common during the peak of the COVID-19 pandemic, possibly a result of delayed presentation, highlighting the need for increased awareness and early recognition of the signs and symptoms of diabetes and DKA, especially during future surges of highly transmissible infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic KetoacidosisHyperglycemic Hyperosmolar Nonketotic ComaCOVID-19Diabetes Mellitus, Type 1HumansChildPandemicsHospitalization

Autor:innen und Institutionen

  • Division of Endocrinology, Boston Children's Hospital, Boston, Massachusetts 02115, USA.
  • Department of Pediatrics, Harvard Medical School, Boston, Massachusetts 02115, USA.
  • Institutional Centers for Clinical and Translational Research, Boston Children's Hospital, Boston, Massachusetts 02115, USA.

ORCID-Profile: Svetlana Azova, Enju Liu, Joseph Wolfsdorf

Förderung

  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases

Zitieren

APA

Azova, S., Liu, E., & Wolfsdorf, J. (2023). Increased Use of Hyperosmolar Therapy for Suspected Clinically Apparent Brain Injury in Pediatric Patients with Diabetic Ketoacidosis during the Peak of the COVID-19 Pandemic. Pediatric Diabetes. https://doi.org/10.1155/2023/5123197

Vancouver

Azova S, Liu E, Wolfsdorf J. Increased Use of Hyperosmolar Therapy for Suspected Clinically Apparent Brain Injury in Pediatric Patients with Diabetic Ketoacidosis during the Peak of the COVID-19 Pandemic. Pediatric Diabetes. 2023. doi:10.1155/2023/5123197

BibTeX
@article{Azova2023,
  author = {Azova, Svetlana and Liu, Enju and Wolfsdorf, Joseph},
  title = {Increased Use of Hyperosmolar Therapy for Suspected Clinically Apparent Brain Injury in Pediatric Patients with Diabetic Ketoacidosis during the Peak of the COVID-19 Pandemic},
  journal = {Pediatric Diabetes},
  year = {2023},
  doi = {10.1155/2023/5123197}
}
Kostenlos starten →